ReviewJournal of translational medicine2024
Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer.
Fen Xiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it